AAVXF
Price
$7.28
Change
+$1.47 (+25.30%)
Updated
Jun 11 closing price
Capitalization
447.04M
CSCI
Price
$3.34
Change
-$0.03 (-0.89%)
Updated
Jun 27 closing price
Capitalization
10.4M
Interact to see
Advertisement

AAVXF vs CSCI

Header iconAAVXF vs CSCI Comparison
Open Charts AAVXF vs CSCIBanner chart's image
Abivax SA
Price$7.28
Change+$1.47 (+25.30%)
Volume$300
Capitalization447.04M
COSCIENS Biopharma
Price$3.34
Change-$0.03 (-0.89%)
Volume$640
Capitalization10.4M
AAVXF vs CSCI Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. CSCI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Hold and CSCI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AAVXF: $7.28 vs. CSCI: $3.34)
Brand notoriety: AAVXF and CSCI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 197% vs. CSCI: 20%
Market capitalization -- AAVXF: $447.04M vs. CSCI: $10.4M
AAVXF [@Biotechnology] is valued at $447.04M. CSCI’s [@Biotechnology] market capitalization is $10.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileCSCI’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • CSCI’s FA Score: 0 green, 5 red.
According to our system of comparison, CSCI is a better buy in the long-term than AAVXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 3 TA indicator(s) are bullish while CSCI’s TA Score has 3 bullish TA indicator(s).

  • AAVXF’s TA Score: 3 bullish, 1 bearish.
  • CSCI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AAVXF is a better buy in the short-term than CSCI.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while CSCI (@Biotechnology) price change was +1.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($447M) has a higher market cap than CSCI($10.4M). CSCI YTD gains are higher at: 20.578 vs. AAVXF (-34.118). CSCI has higher annual earnings (EBITDA): -15.36M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. CSCI (13.8M). CSCI has less debt than AAVXF: CSCI (2.23M) vs AAVXF (92.6M). CSCI has higher revenues than AAVXF: CSCI (9.03M) vs AAVXF (0).
AAVXFCSCIAAVXF / CSCI
Capitalization447M10.4M4,298%
EBITDA-170.04M-15.36M1,107%
Gain YTD-34.11820.578-166%
P/E RatioN/AN/A-
Revenue09.03M-
Total Cash104M13.8M754%
Total Debt92.6M2.23M4,160%
FUNDAMENTALS RATINGS
AAVXF vs CSCI: Fundamental Ratings
AAVXF
CSCI
OUTLOOK RATING
1..100
5076
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
51
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
5852
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/a25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSCI's Valuation (51) in the Biotechnology industry is in the same range as AAVXF (68) in the null industry. This means that CSCI’s stock grew similarly to AAVXF’s over the last 12 months.

CSCI's Profit vs Risk Rating (75) in the Biotechnology industry is in the same range as AAVXF (100) in the null industry. This means that CSCI’s stock grew similarly to AAVXF’s over the last 12 months.

CSCI's SMR Rating (98) in the Biotechnology industry is in the same range as AAVXF (99) in the null industry. This means that CSCI’s stock grew similarly to AAVXF’s over the last 12 months.

CSCI's Price Growth Rating (52) in the Biotechnology industry is in the same range as AAVXF (58) in the null industry. This means that CSCI’s stock grew similarly to AAVXF’s over the last 12 months.

CSCI's P/E Growth Rating (97) in the Biotechnology industry is in the same range as AAVXF (100) in the null industry. This means that CSCI’s stock grew similarly to AAVXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFCSCI
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
39%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
24%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFTHX61.650.65
+1.07%
Baron Fifth Avenue Growth Retail
LAVRX15.360.11
+0.72%
Lord Abbett Fundamental Equity R3
SAPCX34.830.19
+0.55%
ClearBridge Appreciation C
TMCGX15.060.08
+0.53%
Thrivent Mid Cap Growth S
NWXRX11.87N/A
N/A
Nationwide Small Cap Index Instl Svc

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
CSCI - AAVXF
46%
Loosely correlated
-0.89%
SRPT - AAVXF
45%
Loosely correlated
-0.70%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
-7.34%
More

CSCI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSCI has been closely correlated with NCNA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSCI jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-0.89%
NCNA - CSCI
88%
Closely correlated
N/A
RNAC - CSCI
88%
Closely correlated
-6.81%
WINT - CSCI
87%
Closely correlated
+21.49%
BCDA - CSCI
81%
Closely correlated
-3.59%
NRXP - CSCI
79%
Closely correlated
-2.29%
More